SEER Q2 2025 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+31.9% YoY

Gross Profit

$2M52.1% margin

Operating Income

-$21M-506.8% margin

Net Income

-$19M-479.5% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-3.7%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$322M

Total Liabilities

$34M

Stockholders' Equity

$288M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+31.9%
Gross Profit	$2M	$229,000	+821.8%
Operating Income	-$21M	-$27M	+24.2%
Net Income	-$19M	-$23M	+15.0%